ADAR1 Capital Management »

West Pharmaceutical Services shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of West Pharmaceutical Services (WST) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in West Pharmaceutical Services

Tip: Access up to 7 years of quarterly data

All positions including West Pharmaceutical Services held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in West Pharmaceutical Services by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $594k 1.5k 395.71

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding West Pharmaceutical Services

Vanguard Group
BlackRock
BlackRock
Bank of New York Mellon
State Street Corporation
Artisan Partners Limited Partnership
Franklin Resources
Alliancebernstein
Brown Advisory Holdings Incorporated
Geode Capital Management
T. Rowe Price Associates
Durable Capital Partners
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Findlay Park Partners

View all funds holding West Pharmaceutical Services